SOPHiA GENETICS (SOPH) Debt Ratio (2020 - 2026)

SOPHiA GENETICS (SOPH) posted Debt Ratio of 0.29 for Q4 2025, up 0.58% sequentially from 0.29 in Q3 2025, and up 243.52% YoY from 0.09 in Q4 2024.

SOPHiA GENETICS (SOPH) Debt Ratio (2020 - 2026) Analysis & Trends

SOPHiA GENETICS has reported Debt Ratio for 3 years, with the latest figure at 0.29 in Q4 2025.

Quarterly Debt Ratio rose 243.52% year-over-year to 0.29 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.29 (up 243.52% YoY) and the FY2025 annual result came in at 0.29, up 243.52% from the prior year.
Debt Ratio grew to 0.29 in Q4 2025 per SOPH's latest filing, from 0.29 in the prior quarter.
Over five years, Debt Ratio peaked at 0.29 in Q4 2025 and troughed at 0.07 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	-
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	0.37
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	0.29
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	-
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	0.25
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	-
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-
10	SOPHiA GENETICS	553.79 Mn	446.12 Mn	-	0.24

Download Data